Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Times Interest Earned (2023 - 2024)

Camp4 Therapeutics (CAMP) posted Times Interest Earned of -$233.41 for Q1 2026, down 4475.54% sequentially from $5.33 in Q4 2025, and down 1924.08% YoY from $12.8 in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Times Interest Earned (2023 - 2024) Analysis & Trends

Camp4 Therapeutics has reported Times Interest Earned for 4 years, with the latest figure at -$233.41 in Q1 2026.

  • Quarterly Times Interest Earned fell 1924.08% year-over-year to -$233.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160.63 (up 220.22% YoY) and the FY2025 annual result came in at -$0.69, up 15.59% from the prior year.
  • Times Interest Earned slipped to -$233.41 in Q1 2026 per CAMP's latest filing, from $5.33 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $5.64 in Q4 2024 and troughed at -$233.41 in Q1 2026.
  • A 4-year average of -$42.04 and a median of -$11.67 in 2024 frame the typical range for Times Interest Earned.
  • The sharpest annual moves came in 2024 and 2026: Times Interest Earned jumped 103.47% in 2024, then sank 1924.08% in 2026.
  • Over 4 years, Times Interest Earned stood at -$162.36 in 2023, then soared by 103.47% to $5.64 in 2024, then decreased by 5.35% to $5.33 in 2025, then plunged by 4475.54% to -$233.41 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods registered -$233.41, $5.33, and -$15.58 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 96.79
Sep 30, 2024 -218.00
Dec 31, 2023 -162.36
Sep 30, 2023 -262.51